SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000357097-16-000187
Filing Date
2016-09-08
Accepted
2016-09-08 09:19:28
Documents
6
Period of Report
2016-09-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K fcsc090716form8-kdebtoffer.htm 8-K 44381
2 EXHIBIT 4.1 exhibit41formofconvertible.htm EX-4.1 286414
3 EXHIBIT 4.2 exhibit42formofcommonstock.htm EX-4.2 151426
4 EXHIBIT 10.1 exhibit101formofregistrati.htm EX-10.1 154320
5 EXHIBIT 99.1 exhibit991pressrelease0908.htm EX-99.1 12775
6 fcsclogocolor.jpg GRAPHIC 74382
  Complete submission text file 0000357097-16-000187.txt   750970
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31564 | Film No.: 161874911
SIC: 2834 Pharmaceutical Preparations